JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 8 January 2001. doi:10.1083/jcb.152.1.97
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 626K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klingbeil, C. K.
Right arrow Articles by Schlaepfer, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klingbeil, C. K.
Right arrow Articles by Schlaepfer, D. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2001//97 $5.00
The Journal of Cell Biology, Volume 152, Number 1, , 2001 97-110


Original Article

Targeting Pyk2 to β1-Integrin–Containing Focal Contacts Rescues Fibronectin-Stimulated Signaling and Haptotactic Motility Defects of Focal Adhesion Kinase–Null Cells



Candice K. Klingbeila, Christof R. Haucka, Datsun A. Hsiaa, K.C. Jonesa, Shannon R. Reidera, and David D. Schlaepfera

a Department of Immunology, The Scripps Research Institute, La Jolla, California 92037
Department of Immunology, The Scripps Research Institute, IMM26, La Jolla, CA 92037.(858) 784-8227(858) 784-8207

dschlaep{at}scripps.edu

Focal adhesion kinase–null (FAK–/–) fibroblasts exhibit morphological and motility defects that are reversed by focal adhesion kinase (FAK) reexpression. The FAK-related kinase, proline-rich tyrosine kinase 2 (Pyk2), is expressed in FAK–/– cells, yet it exhibits a perinuclear distribution and does not functionally substitute for FAK. Chimeric Pyk2/FAK proteins were created and expressed in FAK–/– cells to determine the impact of Pyk2 localization to focal contacts. Whereas an FAK/Pyk2 COOH-terminal (CT) domain chimera was perinuclear distributed, stable expression of a Pyk2 chimera with the FAK-CT domain (Pyk2/FAK-CT) localized to focal contact sites and enhanced fibronectin (FN)-stimulated haptotactic cell migration equal to FAK-reconstituted cells. Disruption of paxillin binding to the FAK-CT domain (S-1034) inhibited Pyk2/FAK-CT localization to focal contacts and its capacity to promote cell motility. Paxillin binding to the FAK-CT was necessary but not sufficient to mediate the indirect association of FAK or Pyk2/FAK-CT with a β1-integrin–containing complex. Both FAK and Pyk2/FAK-CT but not Pyk2/FAK-CT S-1034 reconstituted FAK–/ cells, exhibit elevated FN-stimulated extracellular signal–regulated kinase 2 (ERK2) and c-Jun NH2-terminal kinase (JNK) kinase activation. FN-stimulated FAK or Pyk2/FAK-CT activation enhanced both the extent and duration of FN-stimulated ERK2 activity which was necessary for cell motility. Transient overexpression of the FAK-CT but not FAK-CT S-1034 domain inhibited both FN-stimulated ERK2 and JNK activation as well as FN-stimulated motility of Pyk2/FAK-CT reconstituted cells. These gain-of-function studies show that the NH2-terminal and kinase domains of Pyk2 can functionally substitute for FAK in promoting FN-stimulated signaling and motility events when localized to β-integrin–containing focal contact sites via interactions mediated by the FAK-CT domain.

Key Words: FAK • Pyk2 • cell migration • integrins • signaling



© 2001 The Rockefeller University Press

C.K. Klingbeil and C.R. Hauck contributed equally to this work.

Abbreviations used in this paper: β-galactosidase, β-gal; CT, COOH-terminal; ERK, extracellular signal–regulated kinase; FAK, focal adhesion kinase; FAT, focal adhesion targeting; FERM, band 4.1, erzin, radixin, and moesin; FN, fibronectin; FRNK, FAK-related nonkinase; HA, hemagglutinin; IP, immunoprecipitation; JNK, c-Jun NT kinase; MBP, myelin basic protein; MEK, mitogen-activated protein kinase; NT, NH2-terminal; P.Tyr, phosphotyrosine; PTK, protein tyrosine kinase; Pyk2, proline-rich tyrosine kinase 2; SH, Src homology; WCL, whole cell lysate.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents